Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviz Technologies (INVZ) Total Non-Current Liabilities (2019 - 2025)

Innoviz Technologies (INVZ) has disclosed Total Non-Current Liabilities for 7 consecutive years, with $29.3 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 15.62% to $29.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.3 million through Dec 2025, up 15.62% year-over-year, with the annual reading at $29.3 million for FY2025, 15.62% up from the prior year.
  • Total Non-Current Liabilities hit $29.3 million in Q4 2025 for Innoviz Technologies, up from $25.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $31.0 million in Q4 2022 to a low of $6.8 million in Q4 2021.
  • Historically, Total Non-Current Liabilities has averaged $24.2 million across 5 years, with a median of $28.7 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 358.79% in 2022 and later decreased 11.72% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $6.8 million in 2021, then skyrocketed by 358.79% to $31.0 million in 2022, then decreased by 7.32% to $28.7 million in 2023, then fell by 11.72% to $25.3 million in 2024, then grew by 15.62% to $29.3 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for INVZ at $29.3 million in Q4 2025, $25.3 million in Q4 2024, and $28.7 million in Q4 2023.